Italian ALS study
(48 patients, after 15 months)
32 TAKING RILUZOLE: 30 percent mortality, disease progressed 50 percent.
16 TAKING RILUZOLE & LITHIUM: 2 deaths-one by heart attack and one had advanced bulbar at the start of the study, 14 others w/ no measurable progression.
Source: Francesco Fornai, University of Pisa
THEY ARE DOING A STUDY WITH A 100 PALS. AND IN THE USA THEY ARE STARTING A CLINICAL TRIAL AT JHU. I'M ON LITHIUM SINCE THURSDAY WITH NO SIDE AFFECTS. IT WILL TAKE ONE MONTH TO FULLY INFILTRATE MY BLOOD.
EXCITED DOESN'T EXPLAIN MY EMOTIONS RIGHT NOW. IT'S MORE GRAND THAN EXCITED-IT IS HOPE! SOMETHING WE PALS LIVE FOR..............